(IMRX)
0.00
0.00 (0.00%)
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
0.00
0.00 (0.00%)
This stock has a consensus price target of $15.90 based on the ratings of 12 analysts. The high is $30.00 and the low is $3.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 3 | $ 15.9 | $ 30 |
| O’zgarish | -39.52% | 220.56% | 504.84% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-03-09 | 121.77% | Needham | $11 → $11 | Reiterates | Buy |
| 2025-11-13 | 303.23% | Chardan Capital | $20 → $20 | Maintains | Buy |
| 2025-10-31 | 202.42% | Leerink Partners | $15 | Initiates Coverage On | Outperform |
| 2025-09-30 | 121.77% | HC Wainwright & Co. | $11 → $11 | Reiterates | Buy |
| 2025-09-26 | 303.23% | Chardan Capital | $13 → $20 | Maintains | Buy |